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PLANT BASED COMPOUNDS INHIBIT PROLIFERATION, ALTER
CYTOMORPHOLOGY AND DECREASE MIGRATION OF HUMAN
ADENOCARCINOMA CELLS

An Abstract of the Thesis by
Devapriya Segaran

Adenocarcinoma is an aggressive form of lung cancer that has a high risk of recurrence
with a survival rate of 33%. In recent years, there has been much interest in the ability of
naturally occurring plant derived phenols to inhibit specific type of cancers. Compounds
like curcumin derived from turmeric, rutin derived from citrus fruits and resveratrol derived
from blueberries have been of particular interest. In this thesis I studied the anti-cancer
effects of the above-mentioned compounds on a human A549 adenocarcinoma cell line.
Inverted phase contrast microscopy was used to observe alterations to the cytomorphology
of cells. An MTT assay was used to measure cell viability. Dose and time dependent A549
cell viability were observed following treatment with curcumin, rutin and resveratrol. The
effects on cell migration after treatment with compounds was determined by woundhealing assay and MTT assay. I found that the survival rates of curcumin treated cells
reduced at higher concentrations after 24 h treatment when compared to rutin and
resveratrol treated cells, although resveratrol showed lower viability than rutin. After 48
hours of treatment the viability of curcumin treated cells dropped to 10% with somewhat
higher survival with rutin (18% viability) and resveratrol (12% viability). Morphological
analysis showed that compound treated cells became round and the normal spindle shape
disappeared. Over a period of 6 h to 24 h, the number of bright circular dead floating cells
increased. Treatment with curcumin and resveratrol strongly reduced wound repair and
significantly inhibited the migration of A549 cells in a concentration dependent manner.
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Rutin treatment reduced wound repair but had a very minimal effect on cell migration.
These findings provide support to the potential utility of curcumin, resveratrol and rutin as
natural molecules with anticancer activity against adenocarcinoma.
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CHAPTER I

INTRODUCTION

1.1 Cancer
Cancer is a disease caused by changes in the DNA that results in cells dividing
uncontrollably and spreading into surrounding tissues. The human body is made up
of trillions of cells that undergoes cell division to form new cells as required by the
body. As a part of the ageing process, new cells are substituted for old, an event
that never happens in cancer cells where old cells never die and new cells are
formed without necessity. Cancer cells continue growing and form overgrowths in
the body called tumors. They are usually solid or strong masses of tissues which
can be malignant or benign [21].
Malignant tumors spread into surrounding tissues and as they develop, they move
to different parts in the body either through the blood stream or lymph system and
initiate new carcinogenic tumors a long way from the original site of emergence. In
contrast, benign tumors lack the ability to either invade neighboring tissue or
metastasize (spread throughout the body). When removed, benign tumors usually
do not grow back, whereas malignant tumors often do. Cancer cells are also often
able to evade the immune system, a network of organs, tissues, and specialized cells
that protects the body from infections and other conditions [47]. Although the
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immune system normally removes damaged or abnormal cells from the body, some
cancer cells can hide from the immune system.

1.2 Difference between normal cells and cancer-causing cells in the human body
Cancer cells differ from normal cells in many respects, causing them to proliferate
uncontrollably and become invasive. Cancer cells are less specialized than normal
cells, which is a significant distinction. That is, while normal cells develop into
very different cell types with unique roles, cancer cells do not [21]. This is one of
the reasons that, unlike normal cells, cancer cells continue to differentiate
indefinitely. Cancer cells are a perversion of normal, functional differentiated cells.
They differentiate into an abnormal and aggressive cell that no longer performs the
functions of the healthy cell (Fig.1.1). Furthermore, cancer cells may miss signals
that usually warn cells to avoid dividing or that trigger a mechanism known as
programmed cell death, or apoptosis, which the body uses to kill unneeded cells.
Cancer cells often affect the normal cells, chemicals, and blood vessels that
accompany and feed a tumor, a region known as the microenvironment [12].
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Figure 1.1: Uncontrollable division of cancer cells and spread into surrounding
tissues vs regular division of normal cells [21].

1.3 Lung cancer and types
Lung cancer occurs as a result of unchecked growth of unusual cells either in one
or in both the lungs. These anomalous cells do not perform the functions of healthy
human cells and may block the function of normal cells. This abnormality interferes
with the lung's normal role of providing oxygen to the human body through blood.
Despite numerous advancements in treatment methods, lung cancer is often not
curable, even when detected early. Lung cancer screening is a demanding, fastpaced, and interdisciplinary area [47]. Lung cancer is usually classified based on
its appearance in microscope as either small cell lung cancer (SCLC) or Non-small
cell lung cancer (NSCLC).
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Since these two forms of lung cancer have distinct traits for development and
distribution, their treatment is very different [42]. As a result, discriminating
between small cell lung cancer and non-small cell lung cancer is clinically
important.

Figure 1.2: Histologic classification of lung cancer. The two major lung cancer
histologic categories (NSCLC and small cell lung carcinoma) and the most
common histologic subtypes among NSCLC (adenocarcinoma, squamous cell
carcinoma, and large cell carcinoma) [42].

NSCLC is the most prevalent form accounting for 85% of lung cancers and is one
of the main causes of death in humans (Fig 1.2). The use of computer-aided
diagnosis and survival estimation for NSCLC is very important in the care of lung
4

cancer patients. Lung cancer also has a poor prognosis, with a five-year survival
rate of only 10% in many countries. Adenocarcinoma including bronchi alveolar
carcinoma accounts for approximately 40% of NSCLC, while squamous cell
carcinoma accounts for approximately 25% - 30% [17]. This study involves the use
of adenocarcinoma cell lines (A546 cells), a part of NSCLC that accounts for the
majority of lung cancers.

1.4 Adenocarcinoma
Adenocarcinoma is a form of cancer that develops in glands that secrete mucus or
fluids in various parts of the body [8]. It is most common in the following cancer
types:
•

Lung cancer- Adenocarcinoma is the most common type of non-small cell
lung cancer [8].

•

Prostate cancer- This is the type of cancer that occurs in the prostate glands,
adenocarcinoma being the cause of 99% of such cancers [31].

•

Pancreatic cancer- This type of adenocarcinoma occurs in pancreatic ducts.

•

Colorectal cancer- This adenocarcinoma occurs in the intestinal glands
inside colon and rectum and is the cause of 95% of colon or rectal cancers
[47].

1.5 Causes of cancer
Cancer has wide range of causes, including genetic, biochemical, occupational, and
environmental exposure to benzene, heavy metals, pesticides, and mineral fibers.
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These factors may function directly or indirectly, inducing the expression of the
malignant phenotype, which controls the progression of the disease. Dietary causes
are responsible for about 30-35% of cancer cases [35]. There is compelling
evidence that diet plays a part in cancer prevention and/or development [13].
Combining this evidence, the Mediterranean diet represents one of the most popular
dietary models currently under consideration in the field of cancer prevention and
treatment outcomes [26].
Cancer prevalence is lower in countries where food habits include a low intake of
beef, a high intake of dairy and alcohol, and regular ingestion of bioactive-nutrientrich fruits and vegetables. In reality, fruits and vegetables contain thousands of
phytochemicals with antioxidant, anti-inflammatory, anticarcinogenic, antiviral,
and antiallergic properties; they are known as carotenoids, vitamins, alkaloids,
nitrogen-containing, organo-sulfuric, and phenolic compounds [32]. In particular,
in vivo and in vitro research, as well as human studies, have indicated that
polyphenols may protect against chronic diseases and have shown an inverse
relationship between polyphenol consumption and the risk of tumor growth [46].
In this study we will assess the ability of several polyphenols to inhibit the growth
and spread of cancer cells.

1.6 Polyphenols against cancer
Polyphenols are a large family of naturally occurring organic compounds that are
chemically distinguished by the presence of several phenol groups. They are
common in plants and have a wide range of structural variations. Polyphenols
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include flavonoids, tannic acid, and ellagitannin, all of which have traditionally
been used as dyes and tanning agents for clothing. Decades of polyphenol studies
has yielded many observations into the role of polyphenols on immune function
[10]. Each polyphenol type targets and binds to one or more receptors on immune
cells, triggering intracellular signaling pathways that eventually control the host
immune response.
Polyphenol-containing dietary interventions can modulate immune responses by
influencing epigenetic mechanisms such as regulatory DNA methylation, histone
alteration, and microRNA-mediated posttranscriptional repression, all of which
modify the expression of genes encoding key immune factors. Immune cells
express many receptors that allow the transmission of external stimuli to activation
processes within the cell in vivo [13]. Currently, researchers are studying a range
of polyphenol receptors. Many studies have investigated the effects of polyphenols
on various types of immune cells, such as primary macrophages, to identify
potential targets [26].
Polyphenols are a significant group of phytochemicals that have received expanded
research interest after it was discovered that they can influence cancer cell
development. Epidemiologic trials provided the first proof that a diet high in
polyphenols, such as fruits and vegetables, substantially decreases the incidence of
multiple cancers [46]. Phenolic compounds influence carcinogenesis by inducing
cell defense mechanisms, including detoxifying and antioxidant enzyme systems,
as well as inhibiting anti-inflammatory and anti-cellular growth signaling
pathways, which result in cell cycle arrest and/or cellular death [35]. Polyphenols
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studied in this research include curcumin derived from turmeric, rutin derived from
citrus fruits and resveratrol derived from blueberries.

1.7 Curcumin
Curcumin(diferuloylmethane)(1,7 bis(4 hydroxy-3-methoxyphenyl)1,6 hepadiene
3,5-dione), (Fig. 1.3) a form of liposoluble polyphenol pigment isolated from the
rhizome of curcuma, has a long history as a dietary supplement and is noted for a
range

of

biological

action

including

anti-inflammatory,

anticoagulant,

hypolipidemic, antioxidant, free radical scavenging, anti-atherosclerosis, etc [4]. It
is the main active compound in the Chinese medicine turmeric which has
significant pharmacological effect [14]. Curcumin, an anti-inflammatory
compound has the ability to inhibit cyclooxygenase-2 (COX-2), lipoxygenase
(LOX), and inducible nitric oxide synthase (iNOS), which are essential for
inflammatory processes [15]. Moreover, inhibition of NF-Kβ signaling pathway
supports anti-inflammatory effect of curcumin in cancer cells. Curcumin
upregulates the heat shock family genes in addition to genes involved in cell cycle
[16].
Curcumin has recently been found in clinical trials to be healthy and well tolerated
in humans. Curcumin at a concentration of 40 µm inhibits the growth of multiple
cancer lines in vitro, including lung cancer [18]. These results strongly indicate that
it has a possible therapeutic use in cancer prevention especially in lung cancer.
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Figure 1.3: Chemical structure of curcumin and curcuminoids
found in turmeric [18].

Curcumin has been suggested to induce cell cycle arrest and activate apoptosismediated cell death in several cancer cell types, including lung cancer [23]. While
it is widely assumed that apoptosis is the primary toxic function of curcumin in
tumor cells, it is unclear if autophagy is triggered in curcumin-induced cancer cell
death [4]. Simultaneously, in recent years, there has been a lot of concern over the
fact that curcumin can upregulate autophagy to achieve its antitumor function. It
was found that curcumin can induce autophagy, a catabolic process for the
degradation and recycling of macromolecules and organelles which can be
activated during stress conditions was identified as an important part of the tumor
control procedure [15].
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1.8 Resveratrol
Resveratrol (3,5,40-trihydroxy-trans-stilbene) is a member of the stilbenoids group
of polyphenols, with two phenol rings bound by an ethylene bridge (Fig.1.4). This
natural polyphenol has been found in over 70 plant species, most commonly the
skin and seeds of grapes, and has been found in trace quantities in red wines and a
number of human foods. It is a phytoalexin that inhibits the growth of pathogens
such as bacteria and fungi. Numerous tests have shown that resveratrol has a very
high antioxidant capacity as a natural food product [41]. Resveratrol also has
antitumor activity and is being treated as a possible candidate for the prevention
and treatment of multiple cancers. It induces promyelocytic leukemia cell
differentiation, and exhibits anticancer properties by mediating apoptosis, arresting
cell cycle progression, antiproliferation and inhibiting ribonucleotide reductase,
ornithine decarboxylase, and cyclooxygenase through modulation of prostaglandin
production [29].

Figure 1.4: Chemical structure of resveratrol and resveratrol glucoside [41]

10

Many in vitro and in vivo experiments have confirmed resveratrol's anticancer
properties, demonstrating that it can suppress all stages of carcinogenesis.
Furthermore, anti-inflammatory and anticarcinogenic effects have been identified.
Resveratrol has received great attention as an upcoming preventive and therapeutic
agent against breast cancer. Indeed, resveratrol is believed to target intracellular
signaling pathway components such as regulators of cell survival and apoptosis,
pro-inflammatory mediators, and tumor angiogenic and metastatic switches by
modulating a distinct set of transcription factors, upstream kinases, and their
regulators [2].
Resveratrol has also shown promise as part of combination therapy, particularly in
breast cancer. A resveratrol concentration of 10 µM/L was able to keep estrogen
metabolites from interacting with DNA [22]. This compound has been shown to
reverse drug resistance in a wide variety of in vitro cell systems by sensitizing
tumor cells to drug-mediated effects in combination with other chemotherapeutic
agents. Resveratrol is also a histone deacetylase inhibitor that display its
antiproliferative action by activating cell cycle arrest, inducing apoptosis and
autophagy, angiogenesis inhibition, increasing reactive oxygen species generation
causing oxidative stress, and mitotic cell death in cancer cells [3]. Resveratrolloaded nanoparticles have also demonstrated antioxidant potential in cancer cells
[48]. Nonetheless, resveratrol delivery is still a major challenge for the
pharmaceutical industry, due to its poor solubility and bioavailability.
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1.9 Rutin
Rutin is a glycoside consisting of the flavonol quercetin and the disaccharide
rutinose (Fig.1.5). It is also known as rutoside, quercetin-3-O-rutinoside, and
sophorin. It is a citrus flavonoid present in many species, including citrus. Many
common plants contain rutin, including buckwheat, apples, black tea, and
vegetables. It has been used in a variety of traditional Chinese medicines and has
been shown to have many positive effects, inhibiting platelet aggregation, reduction
of inflammation, antioxidant activity, and a lowering of blood fat and cholesterol
[1]. In breast cancer MDA-MB-231 cells, rutin has bioactivity and anticancer
activity [7]. Furthermore, rutin protects DNA damage from pro-carcinogens in
HTC hepatic cells. Rutin has also been shown to have in vitro cytotoxic effects on
cancer cell lines, including human colon cancer cells [19].

Figure 1.5: Rutin, a glycoside from quercetin flavonoid [21]

Rutin and its analogues, such as EGCG and quercetin, are effective radical
inhibitors and have been shown to have chemopreventive efficacy in a number of
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colonic cancer cell lines and murine models [29]. In some in vivo models, such as
NK/Ly ascites and B16F10 cells, rutin has antitumor effects [19]. As a result, it was
shown that rutin had a major beneficial effect on reducing the number of
precancerous lesions and inducing apoptosis in large intestine cancer and human
neuroblastoma LAN-5 cells. Anticancer effects of rutin were studied by Yang et.al.,
in Human leukemia HL-60 cells, and it was found that rutin inhibited tumor growth
in a xenograft animal model. It was demonstrated that treatment with 120 mg/kg of
rutin resulted in a reduction of tumor weight and volume when compared with the
control groups. Rutin decreased tumour weight by 62.99% when compared to
control and tumour size was also found to be significantly smaller [24].

Curcumin, resveratrol and rutin have a strong ability to modulate the immune
system and have shown vast anticancer activities against most varieties of cancers,
including adenocarcinoma cells (A549 cell lines), a NSCLC that has become highly
prevalent among the population [34]. Though many studies have been carried out
showing these polyphenols can have anti-tumor activity, a detailed study has not
been done on the effects of minimal dosage of polyphenols on cell migration or on
A549 cells viability. In this study I perform a time and concentration dependent
analysis on the effects of curcumin, rutin and resveratrol on A549 cell’s migration,
viability and cytomorphology.
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CHAPTER II

MATERIALS AND METHODS

2.1 Culture medium preparation
•

450 mL of RPMI complete medium (pH 7.3) was mixed with 100mg/mL
antibiotics (penicillin and streptomycin with a final concentration of 75
µg/mL) and 12% fetal bovine serum (FBS).

•

Cytiva Hyclone RPMI 1640 medium and Gibco FBS was purchased from
Fisher Scientific.

•

The solution was then filtered using vacuum suction having membrane of
pore size 0.2 µm. The media was then stored at 4 ˚C.

2.2 Preparation of stock solutions of compounds
10ml of stock solutions were made for the below mentioned compounds.
•

Curcumin: 3.68 mg of curcumin (1 mM) was dissolved in 1 mL DMSO and
was made 10 mL by adding PBS.

•

Rutin: 6.29 mg of rutin (1 mM) was first dissolved in 1 mL DMSO by
vortex. It was made 10 mL by adding 9 mL PBS.
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•

Resveratrol: 2.28 mg of resveratrol (1 mM) was dissolved in 10 ml PBS and
vortexed.

•

The above stock solutions were filter sterilized using 0.2 µm membrane
filters.

2.3 Cell culture
•

A549 cells were thawed and grown in T-75 flask with RPMI medium for
24 h. They were kept at 37 °C, 5% CO2 in humidified air in an incubator.

•

The cells were then rinsed with 20 ml of pre-warmed PBS and trypsinized
with 0.25% trypsin/0.53 mM EDTA for 15 min.

•

When the cells have been detached the trypsin/EDTA was neutralized by
addition of 10 mL growth medium.

•

The cell suspension was centrifuged for 6 min at 1200 rpm.

•

The supernatant was discarded, and pellet was suspended in 4 mL growth
medium.

•

1 mL of cell suspension was plated in two new T-75 flasks and let grow for
24 h. Remaining cell suspension (2 ml) was frozen in liquid Nitrogen.

•

The logarithmic growth phase for A549 cells were determined by changing
the media every day and passaging the cells once every 2 to 3 days.

2.4 Morphological observation
•

4x104 /mL suspension of A549 cells were seeded in 12-well plates at 1 mL
per well cultured overnight until the cells adhered to the wall.
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•

The cells were exposed to curcumin, rutin and resveratrol (40 µM) and the
same volume of the consumption of DMSO for solubilizing the compounds
was considered a control group.

•

After cultured for 24 h, cell morphological changes were observed and
photographed under inverted phase contrast microscope.

2.5 Cell counting
•

Cell counting was performed by The Neubauer counting chamber
(hemocytometer)

•

10 µL of the cell suspension was taken and pipetted underneath the
coverslip of the hemocytometer.

•

All cells in areas A, B, C and D (each area made up of 16 squares as detailed
for area A in fig. 2.1) were counted.

Figure 2.1: Schematic illustration of a hemocytometer
Picture modified from:
http://www.ruf.rice.edu/~bioslabs/methods/microscopy/cellcounting.html.
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•

The average cell count per area [(A+B+C+D)/4] was calculated.

•

The number of cells per unit volume (cells/mL) was calculated using the
following equation.
Number of cells/mL = average cell count x 104 x dilution factor

•

Required number of cells (taken directly from the cell suspension) in the
required volume was resuspended in the complete cell culture medium and
seeded into appropriate cell culture flasks.

2.6 Cell viability assay
The MTT assay is a colorimetric assay for measuring cell metabolic activity. It is
based on the ability of nicotinamide adenine dinucleotide phosphate (NADPH)dependent cellular oxidoreductase enzymes to reduce the tetrazolium dye MTT to
its insoluble formazan, which has a purple color. This assay therefore measures cell
viability in terms of reductive activity as enzymatic conversion of the tetrazolium
compound to water insoluble formazan crystals by dehydrogenases occurring in the
mitochondria of living cells although reducing agents and enzymes located in other
organelles, such as the endoplasmic reticulum are also involved [43].

•

After trypsinization cells were seeded in 96 well plate at a density of 5000
cells per well in RPMI media.

•

24 h after culture cells were treated with curcumin, rutin and resveratrol at
different concentrations (0 mM, 2 mM, 4 mM, 6 mM and 10 mM)
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•

Cell viability was assessed by MTT assay after 24 h treatment with
curcumin, rutin and resveratrol.

•

The cells were exposed to 0.5 mg/ml of MTT for 6 h at 37 ˚C in the RPMI
medium.

•

Medium and MTT were removed and after solubilization in 100%
isopropanol, the amount of insoluble formazan crystals was evaluated by
measuring the optical density at 570 nm.

•

Each condition was performed in triplicate.

2.7 Scratch Assay
A wound healing assay is a lab technique for studying cell migration and cell–cell
interactions. This is also known as a scratch assay because it involves scratching a
cell monolayer and using a time lapse microscope to capture images at regular
intervals. It's a 2D cell migration method for measuring cell migration in a sheet of
cells semi-quantitatively [20].
•

Cells were detached from T-75 flask by trypsinization and seeded in a 12
well plate such that each well had 200k cells.

•

The cells were grown until they reached 70 – 80% confluency (monolayer).
The confluency was constantly monitored under microscope.

•

The cells were then treated with curcumin, rutin and resveratrol at 2 mM, 4
mM and 8 mM concentrations.

•

The cell layer was scrapped in a straight line using a 1mm pipette tip. The
tip should be kept perpendicular to the bottom of the well.
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•

Another line was scratched perpendicular to the first line to create a cross
in each well. This removed the cell layers.

•

After scratch the cell monolayer was gently washed with PBS to remove
detached cells and replenished with new growth medium.

•

It was then incubated and imaged with phase contrast microscopy for every
6 h till 24 h (6h, 12h and 24h) until cells migrated to meet in the middle.
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CHAPTER III

RESULTS

3.1 Cell morphology
The inverted microscope was used to examine A549 cell morphology alterations. As
expected, untreated lung adenocarcinoma A549 cells showed a long fusiform shape, small
size, clear cell boundaries with consistent pebble-like growth (Fig. 3.1A). Cells were
treated with 40 µM curcumin, rutin and resveratrol and pictures were taken after 24 h
incubation. All three compounds inhibited growth of A549 cells to some extent with
curcumin showing maximum inhibition.
Curcumin caused A549 cells to become round with a disappearance of the normal spindle
shape. Compared with the corresponding control group, bright-circular dead cells floating
increased at 24 h incubation (Fig. 3.1B). Rutin did not affect long fusiform shape of A549
cells but affected cellular contact, making them round after disrupting contacts resulting in
the increase of circular dead floating cells (Fig. 3.1C). Resveratrol caused the cells to
decrease in size with a disappearance of cell boundaries. Resveratrol did not affect the
contacts between cells. Bright field appeared around shrunk cells increasing the number of
floating dead cells (Fig. 3.1D).
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3.1A (Control)

3.1B (40 µM Curcumin)

3.1C (40 µM Rutin)

3.1D (40 µM Resveratrol)

Figure 3.1: Morphology of adenocarcinoma cells under inverted phase contrast
microscopy after 24 h incubation. (A) Morphology of normal A549 cells. (B) Morphology
of A549 cells treated with curcumin (C) Morphology of A549 cells treated with rutin (D)
Morphology of A549 cells treated with resveratrol. Scale bar = 100 µm.
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3.2 Cell viability
We utilised the commonly used MTT assay to quantify cell viability. Succinate
dehydrogenase (SDH) in living cells can reduce exogenously applied MTT (3-(4,5dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) to insoluble formazan, a blueviolet crystalline.The formazan in the cell is dissolved in DMSO and quantified by
measuring absorbance at 570 nm using a microplate reader. The larger the value, the more
live cells.
To assess the effects of the curcumin, rutin and resveratrol on cell viability, we treated
A549 cells, cells with various concentrations of these compounds (0, 2, 4, 6, 8, 10 and 15
µM) for either 24 h or 48 h followed by MTT assays. We found a negative correlation
betweent the viability of A549 cells and both the concentration of the compounds and the
length of treatments.
Curcumin treatment had a significant effect on A549 cells resulting in viability ranging
from 49% with the 2 µM treatment to 30% with the 15 µM treatment after 24 h (Fig.
3.2.1A). Rutin treatment for 24 h resulted in 68% cell viability at 2 µM with a steep
decrease to 27% viable cells at 15 µM (Fig. 3.2.1B). Resveratrol treatment resulted in 57%
cell viability at 2 µM with a drastic decrease to 26% viability at 8 µM (Fig. 3.2.1C). For
the 24 h treatment with the lowest dosage of compound, curcumin showed the most
inhibition followed by resveratrol and rutin (Fig. 3.2.1D). When the incubation time was
increased to 48 h, viability fell to 10% for curcumin (Fig. 3.2.2A), 12% for resveratrol
(Fig. 3.2.2B) and 18% for rutin at 15 µM (Fig. 3.2.2C). The cell viability was significantly
reduced with an incubation period of 48 h at higher concentrations irrespective of the
compounds (Fig. 3.2.2D).
22
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Figure 3.2.1: The inhibitory effects of various compounds on lung adenocarcinoma cells
(A549) after 24h incubation. (A) The inhibitory effect of curcumin on the proliferation of
A549 cells. Cells were plated at 5 x 103 cells per dish in the absence and the presence of
curcumin.Time-dependent decrease in the number of A549 cell at the indicated
concentrations. As control, the cells were treated without curcumin. (B) The inhibitory
effect of rutin on the proliferation of A549 cells. Cells were plated at 5 x 103 cells per dish
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in the absence and the presence of rutin.Time-dependent decrease in the number of A549
cell at the indicated concentrations. Control cells were not treated with rutin. (C) The
inhibitory effect of resveratrol on the proliferation of A549 cells. Cells were plated at 5 x
103 cells per dish in the absence and the presence of resveratrol. Time-dependent decrease
in the number of A549 cell at the indicated concentrations. As control, the cells were treated
without resveratrol. (D) Comparative analysis of curcumin, rutin and resveratrol after 24h
incubation. Thebars represent mean viability across 5 replicates +/- standard error .
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Figure 3.2.2: The inhibitory effects of various compounds on lung adenocarcinoma cells
(A549) after 48 h incubation. (A) The inhibitory effect of curcumin on the proliferation of
A549 cells. Cells were plated at 5 x 103 cells per dish in the absence and the presence of
curcumin.Time-dependent decrease in the number of A549 cell at the indicated
concentrations. Control cells were not treated with curcumin. (B) The inhibitory effect of
rutin on the proliferation of A549 cells. Cells were plated at 5 x 103 cells per dish in the
absence and the presence of rutin.Time-dependent decrease in the number of A549 cell at
the indicated concentrations. As control, the cells were treated without rutin. (C) The
inhibitory effect of resveratrol on the proliferation of A549 cells. Cells were plated at 5 x
103 cells per dish in the absence and the presence of resveratrol. Time-dependent decrease
in the number of A549 cell at the indicated concentrations. As control, the cells were treated
without resveratrol. (D) Comparative analysis of curcumin, rutin and resveratrol after 48h
incubation. The bars represent mean viability across 5 replicates +/- standard error.
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3.3 Scratch Assay
Cell migration is a finely regulated process including successive steps of cell adhesion and
de-adhesion. In order to assess the ability of compounds to inhibit cancer cell motility,
scrape damaged A549 monolayers were incubated in the presence of curcumin, rutin and
resveratrol (15 µM) at three different time intervals (0 h, 12 h and 24 h). A cell-free area
in a confluent monolayer is formed in this assay by removing the cells from the area by
mechanical disruption. The cells migrate into the gap after being exposed to the cell-free
environment. In this study, the monolayer was scratched with a pipette tip and the
migration into the gap was imaged over several hours using a transmitted-light microscope
equipped for live-cell imaging.
Control cells completely covered the wounded area after 24 h of incubation at 37 oC (Fig.
3.3c). In contrast, treatment with curcumin, rutin and resveratrol strongly reduced wound
repair and significantly inhibited the migration of both A549 at 5 µM concentration (Fig.
3.3d – 3.3l ).

3.3a (0h)

3.3b (12h)
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3.3c (24h)

3.3d (0h)

3.3e (12h)

3.3g (0h)

3.3h (12h)

3.3j (0h)

3.3k (12h)

3.3f (24h)

3.3i (24h)

3.3l (24h)

Figure 3.3: The inhibitory effects of various compounds on the migration of human
adenocarcinoma cells photographed at 0th hour, 12th hour and 24th hour. The zone between
the two lines (represented by arrows) indicates the area occupied by the initial wound.
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(3.3a, 3.3b, 3.3c) Scratch assay of control groups without treatment with compounds at 0th
hour, 12th hour and 24th hour, respectively. (3.3d, 3.3e, 3.3f) Scratch assay of A549 cells
treated with 5 µM curcumin at 0th hour, 12th hour and 24th hour respectively. (3.3g, 3.3h,
3.3i) Scratch assay of A549 cells treated with 5 µM rutin at 0th hour, 12th hour and 24th
hour respectively. (3.3j, 3.3k, 3.3l) Scratch assay of A549 cells treated with 5 µM
resveratrol at 0th hour, 12th hour and 24th hour, respectively.
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CHAPTER IV

DISCUSSION

Polyphenols have broad applications and are considered to be a safe and effective antitumor
drug. However, the mechanism of the antitumor activity of polyphenols like curcumin,
rutin and resveratrol is still not fully elucidated. In this study, the human lung
adenocarcinoma A549 cell line was selected as experimental cells. The anti-proliferation
mechanism of curcumin, rutin and resveratrol in A549 cells was examined.
Morphologically, curcumin (40 µM) administration caused the cells to lose their normal
long shuttle shape and resulted in the increase of floating dead cells. This effect was time
dependent (Fig. 3.1B). Rutin did not affect long fusiform shape of A549 cells but affected
cellular contact, making them round after disrupting contacts resulting in the increase of
circular dead floating cells (Fig. 3.1C). Resveratrol caused the cells to decrease in size with
a disappearance of cell boundaries. Resveratrol did not affect the contacts between cells.
Bright fields appeared around shrunken cells with an increase in the number of floating
dead cells (Fig. 3.1D).
Curcumin could significantly inhibit the proliferation of human lung adenocarcinoma
A549 cells at various concentrations and time points. After 24 hours, curcumin therapy had
a major effect on A549 cells, with viability ranging from 49 percent with the 2µM treatment
to 30 percent with the 15µM treatment (Fig. 3.2.1A). Rutin therapy for 24 hours resulted
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in 68 percent cell viability at 2µM, decreasing to 27 percent viable cells at 15 µM (Fig.
3.2.1B). Resveratrol therapy resulted in 57 percent cell viability at 2µM, but just 26 percent
viability at 8µM (Fig. 3.2.1C). Curcumin inhibited the most in the 24h treatment with the
lowest compound dose, followed by resveratrol and rutin. When the incubation period was
raised to 48 hours, viability dropped to 10% for curcumin (Fig. 3.2.2A), 12% for resveratrol
(Fig. 3.2.2B), and 18% for rutin at 15µM. (Fig. 3.2.2C). With a 48-hour incubation time at
higher concentrations, cell viability was greatly decreased.
Previous studies have shown that polyphenols suppressed the growth of multiple cancer
lines. Here, evidence has been obtained that curcumin, rutin and resveratrol even at very
low concentrations, could effectively inhibit the proliferation of lung cancer A549 cells,
but the specific mechanism needs to be further explored. Cancer cells develop a variety of
distinguishing characteristics as the tumor progresses. These abilities include the ability to
proliferate in the absence of exogenous growth-promoting or growth-inhibitory signals, to
invade neighboring tissues and spread to distant sites, to induce an angiogenic response,
and to evade cell proliferation-limiting mechanisms including apoptosis. These
characteristics are due to changes in the cellular signaling pathways that regulate cell
proliferation, motility, and survival in normal cells. Many of the proteins currently being
researched as potential cancer therapy targets are signaling proteins that are part of these
pathways [8]. Although the mechanism of polyphenols studied is not known, they may act
by interfereing with the activity of these signalling pathways.
The main biological characteristics of tumor cells are uncontrolled proliferation and higher
migration ability. Cell adhesion is an important mechanism in many biological processes,
including growth, tissue structure maintenance, angiogenesis, and tumor metastasis. Cells
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undergo programmed cell death in the absence of sufficient extra-cellular matrix (ECM)
interactions, which are primarily mediated by integrins [38]. Therefore, the
characterization of new anti-integrin agents is of considerable utility for the development
of therapies. Cancer cell metastasis involves multistep cellular processes, commencing
with cell migration and invasion. Cell migration is tightly regulated by coordinated
remodeling of membrane and actin cytoskeleton. Although the detailed mechanisms are
not yet understood, it is clear that dynamic and reciprocal interactions between cell
adhesion molecules, ECM and soluble factors are essential. This study showed that
curcumin, rutin and resveratrol treated A549 cells have a decreased migratory capacity in
scratch wound assay at very low concentration of 5µM (Fig. 3.3a – 3.3l). The inhibitory
effect of curcumin, rutin and resveratrol against lung cancer A549 cells on cell migration
is likely due to the reduced attachment to ECM proteins observed in the presence of these
polyphenols. Future studies could investigate the effects of polyphenols on integrin
expression patterns. Their effects on structural modifications of actin microfilament and its
dynamics can possibly be analyzed.

31

CHAPTER V

CONCLUSION

Epidemiological and dietary intervention research in a variety of animal models and cancer
cell lines have recently suggested that diet-derived natural compounds like flavonoids that
are polyphenols may be useful as cancer chemopreventative agents [13]. Flavonoids of the
flavonol type, such as rutin, resveratrol, and curcumin, have been confirmed to have a
broad range of pharmacological properties, including antioxidant, antimicrobial,
antifungal, and antiallergic activity, which have been used in human medicine and nutrition
[34]. In addition, polyphenols have a wide range of pharmacological benefits for the
treatment of chronic diseases including diabetes, hypertension, and cancer [46].
In this study I present data that supports the growing evidence that polyphenols, especially
rutin, curcumin and resveratrol, could significantly inhibit the proliferation of A549 cells
as well as alter cytomorphology. I found that these compounds negatively affected A549
cell viability over 48h incubation and also reduced cancer cell migration at a very low
concentration (2µM) in scratch assays.
Due to the wide range of effects of natural compounds and the complexity of cell death,
elucidating the mechanism of action of these compounds will require further study. We
can, however, conclude that the beneficial activity of curcumin, rutin and resveratrol
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against A549 lung cancer cells at extremely low doses make them attractive potential antitumor agents that can easily be delivered through dietary changes and/or supplementation.
It is also worth noting that the effects of curcumin, rutin and resveratrol may differ
depending on cell type. Further studies with additional cell types will provide more
information regarding the potential utility of these compounds against multiple types of
cancer. The future study of non-apoptotic cell death mechanisms induced by polyphenols
may provide targets of plant-derived compounds for future cancer therapeutics and become
a powerful new direction for antitumor research and therapy.
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